Skip to main content


Latest articles

17-09-2019 | Diabetes | News | Article

PIONEER data support oral semaglutide across a wide range of patients

Researchers at the 55th EASD Annual Meeting in Barcelona, Spain, have presented primary data and subanalyses from a number of the PIONEER trials investigating the efficacy of oral semaglutide in people with type 2 diabetes.

17-09-2019 | Diabetes | News | Article

Suboptimal glycemic control shown in adults with type 1 diabetes

Results of the SAGE study demonstrate suboptimal glycemic control among adults of all ages with type 1 diabetes across the globe.

17-09-2019 | Diabetes | News | Article

CGM benefits persist with long-term use

The COMISAIR-2 researchers have reported that use of continuous glucose monitoring by people with type 1 diabetes remains high over 3 years, resulting in continued glycemic benefits.

16-09-2019 | Diabetes | News | Article

Diabetes incidence may be falling in many countries

A systematic review in The BMJ suggests the incidence of diabetes may be falling in many countries, with researchers suggesting preventive strategies may be proving effective.

16-09-2019 | Diabetes | News | Article

DEFINE-HF: Further support for add-on dapagliflozin as a treatment option for heart failure

Results of the DEFINE-HF trial indicate that add-on dapagliflozin treatment may improve health status among people with established heart failure and reduced ejection fraction.

13-09-2019 | Diabetes | Main feed | News

Prescription records best clinical indicator of future diabetes medication adherence

Adherence to first-line diabetes medication, ascertained from prescription records, is the only routine clinical variable that is a strong indicator of people’s adherence to second-line treatment, say researchers.

12-09-2019 | Diabetes | News | Article

Strength, balance training benefits people with diabetic peripheral neuropathy

Short-term structured strength and balance training does not improve quality of life in patients with type 2 diabetes-related peripheral neuropathy, but may increase functional status and balance confidence, research shows.

11-09-2019 | Diabetes | News | Article

Diabetes linked to increased frailty during aging

Older people with diabetes are frailer throughout aging than those without diabetes, study findings indicate.

10-09-2019 | Diabetes | News | Article

Type 1 diabetes severe hypoglycemia predictors identified in HypoCOMPaSS analysis

Researchers have identified factors that predict repeated very low blood sugar among adults with type 1 diabetes who have suboptimal awareness of hypoglycemia.

09-09-2019 | Diabetes | News | Article

Meta-analysis supports use of SGLT2 inhibitors to prevent kidney failure

Findings from a systematic review and meta-analysis suggest that SGLT2 inhibitors reduce the risk for major adverse kidney outcomes among people with type 2 diabetes, regardless of baseline kidney function.

06-09-2019 | Diabetes | News | Article

Novel risk score stratifies HHF risk in type 2 diabetes

Researchers have developed a novel clinical risk score for hospitalization for heart failure, which identifies people with type 2 diabetes most likely to benefit from sodium-glucose cotransporter 2 inhibition.

05-09-2019 | Diabetes | News | Article

Metabolic surgery may improve cardiovascular prognosis in type 2 diabetes

People with type 2 diabetes and obesity who undergo metabolic surgery have a significantly lower risk for major adverse cardiovascular events than those who do not receive surgery, observational study data show.

04-09-2019 | Diabetes | News | Article

Real-world data verify cardioprotective benefits of SGLT2 inhibitors

Real-world data published in The BMJ confirm the cardioprotective benefits of SGLT2 inhibitor use, relative to DPP-4 inhibitor use, in people with type 2 diabetes.

03-09-2019 | Diabetes | News | Article

Microvascular benefits of lowest HbA1c target in type 1 diabetes questioned

Aiming for the lowest international targets in glycated hemoglobin levels may not protect against retinopathy and nephropathy in patients with type 1 diabetes, research suggests.

03-09-2019 | Diabetes | News | Article

Diabetes medications need review ahead of weight-loss interventions

The specific medications people are taking for diabetes can affect their success when they undertake a weight-loss program, say researchers.

02-09-2019 | Diabetes | News | Article

Dapagliflozin ‘offers a new approach’ for treating heart failure

The addition of dapagliflozin to standard treatment may be beneficial for patients with established heart failure and reduced ejection fraction, indicate findings from the DAPA-HF trial.

01-09-2019 | Diabetes | News | Article

THEMIS: No overall benefit of ticagrelor in people with diabetes, coronary artery disease

Findings from the THEMIS trial suggest that the addition of ticagrelor to aspirin treatment reduces the incidence of ischemic cardiovascular events among people with type 2 diabetes and stable coronary artery disease, but at the cost of an increased risk for major bleeding, resulting in an unfavorable risk:benefit ratio.

30-08-2019 | Diabetes | News | Article

Long dough fermentation reduces pizza challenges for type 1 diabetes

Hyperglycemia in children with type 1 diabetes after eating pizza can be reduced by fermenting the dough for longer, Italian research shows.

30-08-2019 | Diabetes | News | Article

Repeat testing necessary for accurate hyperglycemia screening

Testing both glycated hemoglobin and fasting plasma glucose gives a more reliable hyperglycemia diagnosis than either on its own, but a follow-up screening test remains essential, say researchers.

28-08-2019 | Diabetes | News | Article

Depressive symptoms confound diabetes prevention efforts

The effectiveness of interventions to increase objectively measured physical activity in people at high risk for developing type 2 diabetes declines in line with symptoms of depression within the normal range, say researchers.